Small molecules have big impact for TB bacteria

Mar 31, 2010

Mycobacterium tuberculosis (Mtb) possesses extraordinary survival ability by masking itself from the host immune system and persisting for decades inside the host. Speaking at the Society for General Microbiology's spring meeting in Edinburgh today, Dr Kristine Arnvig provides further insight into how the bacterium causes tuberculosis (TB) by fine-tuning its behaviour in response to its surroundings to escape detection.

Understanding the genetic tools and tricks used by Mtb to control its behaviour is likely to give an idea how it manages to survive for such long periods. "This kind of research should give us new biological targets upon which to base new, faster-acting drugs and vaccines and enable us to take on TB - a that is one of the biggest threats to global health," suggested Dr Arnvig.

Together with her colleague Dr Douglas Young at the National Institute for Medical Research, London, Dr Arnvig demonstrated that, like other , Mtb can produce tiny molecules called small RNAs. These molecules are able to subtly tweak the production of key bacterial components in response to environmental signals. This helps maximise the survival of the pathogen allowing it to progressively break down .

Small RNAs float around the cell and are often the mirror image of key bacterial genes, to which they can stick to like Velcro™. This mechanism can enhance or inhibit the normal production of bacterial molecules from these genes. Other pathogenic bacteria including Salmonella spp, and Vibrio cholerae are already known to rely on small RNAs when adapting to their host environments and causing disease.

The small RNAs in Mtb are induced under certain stress conditions that signal as a warning to the bacterium."We think that the small RNAs may play a crucial role in allowing Mtb to alter its pattern of in response to the environmental conditions that it experiences within the host during infection," explained Dr Arnvig. "Understanding this regulatory system will help us to design new drugs that specifically attack the persistent form of Mtb which manages to hide from the immune system and resist the action of existing drugs."

Explore further: Mycologist promotes agarikon as a possibility to counter growing antibiotic resistance

Provided by Society for General Microbiology

not rated yet
add to favorites email to friend print save as pdf

Related Stories

Fat clue to TB awakening

Mar 28, 2010

The factors instrumental in triggering latent tuberculosis (TB) infection to progress into active disease have long remained elusive to researchers. New insight into the mystery is provided by Professor David ...

Tuberculosis: On the path to prevention

Dec 01, 2009

Why do some people who are exposed to tuberculosis not become infected or develop the disease? Dr. Erwin Schurr and his team at the Research Institute from the McGill University Health Centre (RI-MUHC), in collaboration with ...

Bile sends mixed signals to E. coli

Mar 30, 2010

Bile secretions in the small intestine send signals to disease-causing gut bacteria allowing them to change their behaviour to maximise their chances of surviving, says Dr Steve Hamner, presenting his work ...

Recommended for you

YEATS protein potential therapeutic target for cancer

Oct 23, 2014

Federal Express and UPS are no match for the human body when it comes to distribution. There exists in cancer biology an impressive packaging and delivery system that influences whether your body will develop cancer or not.

Precise and programmable biological circuits

Oct 23, 2014

A team led by ETH professor Yaakov Benenson has developed several new components for biological circuits. These components are key building blocks for constructing precisely functioning and programmable bio-computers.

User comments : 0